New: NCI-funded clinical trial search
Mednet Logo

For a patient with metastatic gastric adenocarcinoma with CT showing NED after 4 months of FOLFOX + pembrolizumab + trastuzumab, would you consider resection of the primary and/or a chemo break?

Would your thinking change if the patient continues to be NED after an unplanned chemo break, e.g. for insurance issues?
2 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center
Answered on

This question is about a patient with gastric cancer who has a complete response to therapy with chemotherapy, trastuzumab, and checkpoint inhibitor blockade. The patient had a radiographic CR after 4 months of therapy. How to proceed from here is an interesting question, and would be influenced by ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · Providence Hood River Memorial Hospital
Answered on

I absolutely agree with @Dr. First Last about the duration of systemic therapy (6-12 months at a minimum) before considering surgical management. Most of the surgeons I work with wouldn't even think about operating with curative intent before the 12 month mark.

I also think that the nature of the me...

Join for free or sign in to see the full answer